CAIAC Fund Management AG, Ten Percent Owner at Helix BioPharma, holds 26.36M shares in Helix BioPharma (Ticker: TSE:HBP). Most recently, CAIAC Fund Management AG Bought C$26,363,172 shares of Helix BioPharma on Sep 07, 2020 for an estimated value of 13.18M.